Clinical Trials Browser

Carcinosarcoma, Glioma, Seminoma, Adenocarcinoma, Clear Cell, Carcinoma, Small Cell, Sex Cord-Gonadal Stromal Tumors, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

Clinical Trials

SUR-CAN

Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

TEMPO

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Abemaciclib in Newly Diagnosed Meningioma Patients

Palbociclib and Pembrolizumab In Central Nervous System Metastases

NF114

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

PNOC029

Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Brain Imaging Biomarkers in Patients With Brain Metastasis

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Surgical Pembro +/- Olaparib w TMZ for rGBM

Methimazole in Patients With Progressive Glioblastoma

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

GABLE

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

REPOSE

MK-6482-015

MEMMAT

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

PEDS-PLAN

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

MOMENTUM-1

Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients

Phenix

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

SIB-DOPA